omega-n-methylarginine has been researched along with Cyanosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernheim, A; Brunner-La Rocca, HP; Julius, B; Kiowski, W; Oechslin, E; Schindler, R | 1 |
1 trial(s) available for omega-n-methylarginine and Cyanosis
Article | Year |
---|---|
Systemic endothelial dysfunction in adults with cyanotic congenital heart disease.
Topics: Acetylcholine; Adult; Antihypertensive Agents; Cyanosis; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Heart Defects, Congenital; Hemoglobins; Humans; Microcirculation; Nitroprusside; omega-N-Methylarginine; Oxygen; Peptides, Cyclic; Polycythemia; Vasoconstriction; Vasodilation; Vasodilator Agents | 2005 |